9-26995598-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The ENST00000380055.6(LRRC19):​c.1036C>T​(p.His346Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,454,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

LRRC19
ENST00000380055.6 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.67
Variant links:
Genes affected
LRRC19 (HGNC:23379): (leucine rich repeat containing 19) Predicted to enable signaling receptor activity. Acts upstream of or within positive regulation of NIK/NF-kappaB signaling. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
IFT74 (HGNC:21424): (intraflagellar transport 74) This gene encodes a core intraflagellar transport (IFT) protein which belongs to a multi-protein complex involved in the transport of ciliary proteins along axonemal microtubules. IFT proteins are found at the base of the cilium as well as inside the cilium, where they assemble into long arrays between the ciliary base and tip. This protein, together with intraflagellar transport protein 81, binds and transports tubulin within cilia and is required for ciliogenesis. Naturally occurring mutations in this gene are associated with amyotrophic lateral sclerosis--frontotemporal dementia and Bardet-Biedl Syndrome. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26747775).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LRRC19NM_022901.3 linkuse as main transcriptc.1036C>T p.His346Tyr missense_variant 5/5 ENST00000380055.6 NP_075052.1 Q9H756
IFT74NM_025103.4 linkuse as main transcriptc.587+5403G>A intron_variant ENST00000380062.10 NP_079379.2 Q96LB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LRRC19ENST00000380055.6 linkuse as main transcriptc.1036C>T p.His346Tyr missense_variant 5/51 NM_022901.3 ENSP00000369395.5 Q9H756
IFT74ENST00000380062.10 linkuse as main transcriptc.587+5403G>A intron_variant 1 NM_025103.4 ENSP00000369402.5 Q96LB3-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000798
AC:
2
AN:
250508
Hom.:
0
AF XY:
0.00000738
AC XY:
1
AN XY:
135468
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1454070
Hom.:
0
Cov.:
29
AF XY:
0.00000276
AC XY:
2
AN XY:
723914
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 14, 2022The c.1036C>T (p.H346Y) alteration is located in exon 5 (coding exon 4) of the LRRC19 gene. This alteration results from a C to T substitution at nucleotide position 1036, causing the histidine (H) at amino acid position 346 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.022
T
Eigen
Uncertain
0.20
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.27
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.5
M
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.12
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.011
D
Polyphen
0.96
P
Vest4
0.26
MutPred
0.57
Gain of phosphorylation at H346 (P = 0.082);
MVP
0.79
MPC
0.086
ClinPred
0.89
D
GERP RS
3.5
Varity_R
0.095
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1273135932; hg19: chr9-26995596; API